Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis (Q24678827)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

9 January 2020

main subject

0 references

author

Henk-Jan Guchelaar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

H J M van Kan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G J Groeneveld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Kalmijn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Spieksma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

L H van den Berg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Clinical Pharmacology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

310-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping

9 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

A validated HPLC assay to monitor riluzole plasma or serum concentrations in patients with amyotrophic lateral sclerosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

The use of caffeine for enzyme assays: a critical appraisal

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

Riluzole serum concentrations in patients with ALS: associations with side effects and symptoms.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02233.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2004.02233.X

Impact of random and fixed (optimal) sampling approach on the Bayesian estimation of clearance.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884790

Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures

28 November 2018

1 reference

12 December 2020

Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of riluzole in white subjects

1 reference

12 December 2020

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

12 December 2020

Neuroprotective effects of riluzole in ALS CSF toxicity

1 reference

12 December 2020

10.1111/J.1365-2125.2004.02233.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752377%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference